Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06958250 · ClinicalTrials.gov registry record · NA
Novel Endoscopic Bite Block
A NA study of Gastric Disease, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06958250 is a NA study of Gastric Disease that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06958250, a NA study of Gastric Disease, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This feasibility study aims to assess the safety and effectiveness of the Novel Endoscopic Bite Block. The device will be utilized in subjects undergoing routine outpatient upper endoscopy. The investigator hypothesizes that its innovative design will reduce complications associated with bite block positioning, thereby improving procedural efficiency and patient safety.
Conditions Studied
Interventions
- DEVICE Novel Bite Block
Study Locations (1)
New Jersey
- Penn Medicine Princeton Health - Plainsboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-12-22 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06958250
The ClinicalTrials.gov registry entry for NCT06958250 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gastric Disease appearing as the primary indexed condition, and to 1 intervention - of which Novel Bite Block is the first listed.
NCT06958250 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT06958250 about?
NCT06958250 is a clinical study titled "Novel Endoscopic Bite Block". This feasibility study aims to assess the safety and effectiveness of the Novel Endoscopic Bite Block. The device will be utilized in subjects undergoing routine outpatient upper endoscopy. The investigator hypothesizes that its innovative design will reduce complications associated with bite block ...
What is the current status of trial NCT06958250?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-12-22. Estimated completion is 2026-12.
What conditions does trial NCT06958250 study?
This clinical trial studies the following conditions: Gastric Disease.
What interventions are being tested in trial NCT06958250?
The interventions under investigation include: Novel Bite Block (DEVICE).
Who is sponsoring clinical trial NCT06958250?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06958250 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastric Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.